Clinical Trials Browser

Phase 2 × Pancreatic Ductal Adenocarcinoma × Gemcitabine × Clear all

NCT04134468 2020-01-31

MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Ductal Adenocarcinoma